CANbridge Life Sciences Competitors and Similar CompaniesClear all
CANbridge Life Sciences's competitors and similar companies include BioCryst Pharmaceuticals, Bioiberica, Boston Analytical and Proteros.
 CANbridge Life Sciences CANbridge Life Sciences is a biopharmaceutical company accelerating development and commercialization of specialty healthcare products for serious and critical medical conditions. |  BioCryst Pharmaceuticals BioCryst Pharmaceuticals designs, optimizes and develops novel small-molecule drugs that block key enzymes to treat rare diseases. |  Bioiberica Bioiberica is a life science company engaged in the identification, extraction, and development of animal-derived biomolecules. |  Boston Analytical Boston Analytical is a company that provides analytical testing services to support CMC for drug development and release testing. | ||
Founding Date | Founding Date 2012 | Founding Date 1986 | Founding Date 1975 | Founding Date 1987 | Founding Date 2000 |
Type | Type Private | Type Public | Type Subsidiary | Type Subsidiary | Type Subsidiary |
Tags | |||||
Locations | Locations CN HQ Hangzhou Shi, CN Cambridge, US | Locations Durham, US HQ Hoover, US | Locations Esplugues de Llobregat, ES HQ Barcelona, ES Palafolls, ES | Locations Salem, US HQ | Locations Planegg, DE HQ Cambridge, US |
Employees | Employees 506% decrease | Employees 14040% increase | Employees 332 | Employees 2441% decrease | Employees 147 |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $874.8m (FY, 2025) | Revenue (est.) $346.7m (FY, 2018) | Revenue (est.) N/A | Revenue (est.) N/A |
Cost of goods | Cost of goods N/A | Cost of goods $19.1m (FY, 2025) | Cost of goods $190.3m (FY, 2018) | Cost of goods N/A | Cost of goods N/A |
Gross profit | Gross profit N/A | Gross profit $855.8m (FY, 2025) | Gross profit $156.4m (FY, 2018) | Gross profit N/A | Gross profit N/A |
Net income | Net income N/A | Net income $263.9m (FY, 2025) | Net income $40.5m (FY, 2018) | Net income N/A | Net income N/A |
Funding | |||||
Total funding raised | Total funding raised $ 224.1m | Total funding raised $ 1.9m | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 7m |
For sources of this data, please see the company profile
View Company Profiles
BioCryst Pharmaceuticals
HQ
Durham, US
Employees
140↑ 40% increase
BioCryst Pharmaceuticals designs, optimizes and develops novel small-molecule drugs that block key enzymes to treat rare diseases.
View companyBioiberica
HQ
Esplugues de Llobregat, ES
Bioiberica is a life science company engaged in the identification, extraction, and development of animal-derived biomolecules.
View companyBoston Analytical
HQ
Salem, US
Boston Analytical is a company that provides analytical testing services to support CMC for drug development and release testing.
View company
Proteros
HQ
Planegg, DE
Proteros biostructures is a company that provides early-stage drug discovery services.
View company